HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raimon Sanmarti Selected Research

Raimon Sanmarti Research Topics

Disease

19Rheumatoid Arthritis
03/2022 - 04/2003
4Psoriatic Arthritis
12/2018 - 05/2012
3Synovitis
01/2022 - 08/2014
3Necrosis
01/2018 - 11/2012
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2020
2Palindromic rheumatism
01/2020 - 08/2014
2Ankylosing Spondylitis
01/2019 - 06/2009
2Arthritis (Polyarthritis)
01/2019 - 01/2018
1Hypersensitivity (Allergy)
09/2021
1Pain (Aches)
01/2019
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
12/2018
1Rheumatic Diseases (Rheumatism)
05/2018
1Joint Diseases (Joint Disease)
01/2016
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2009
1Infections
06/2009
1Headache (Headaches)
06/2009
1Injection Site Reaction
06/2009

Drug/Important Bio-Agent (IBA)

5Leukocyte L1 Antigen Complex (Calgranulin)IBA
03/2022 - 12/2015
5Proteins (Proteins, Gene)FDA Link
09/2021 - 08/2014
5Etanercept (Enbrel)FDA Link
01/2016 - 06/2009
4tocilizumab (atlizumab)FDA Link
10/2019 - 12/2015
4Infliximab (Remicade)FDA Link
01/2019 - 01/2008
3Tumor Necrosis Factor InhibitorsIBA
12/2018 - 11/2012
3Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2016 - 12/2015
3Adalimumab (Humira)FDA Link
01/2016 - 08/2015
2C-Reactive ProteinIBA
01/2022 - 01/2016
2AntibodiesIBA
01/2022 - 09/2021
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2018
2AutoantibodiesIBA
01/2022 - 01/2020
2Pharmaceutical PreparationsIBA
01/2018 - 01/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012 - 01/2008
1Janus Kinase InhibitorsIBA
01/2022
1Immunoglobulin E (IgE)IBA
09/2021
1Abatacept (Orencia)FDA Link
09/2021
1Anti-Idiotypic AntibodiesIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2019
1GlucocorticoidsIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
12/2018
1Methotrexate (Mexate)FDA LinkGeneric
05/2018
1Rituximab (Mabthera)FDA Link
11/2012
1N 30IBA
06/2009
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2008
1Antirheumatic Agents (DMARD)IBA
04/2003

Therapy/Procedure

2Therapeutics
01/2019 - 01/2018
1Biological Therapy
05/2012